Maturation of cancer vaccines. A meeting report on 'Cancer Vaccines 1996,' sponsored by the Cancer Research Institute, held October 7-9, 1996.
Pardoll
D
D
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA. dmpardol@welchlink.welch.jhu.edu
D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D016827:CD8 Antigens; D019496:Cancer Vaccines; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases / Q000235:genetics; D015395:Histocompatibility Antigens Class I; D006801:Humans; D008545:Melanoma / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011518:Proto-Oncogene Proteins; D011994:Recombinant Proteins
D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D016827:CD8 Antigens; D019496:Cancer Vaccines; D015395:Histocompatibility Antigens Class I; D011518:Proto-Oncogene Proteins; D011994:Recombinant Proteins; C495900:CDK4 protein, human; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases